Literature DB >> 23096016

Neutrophil gelatinase-associated lipocalin (NGAL): the clinician's perspective.

Gianfranco Cervellin, Salvatore di Somma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23096016     DOI： 10.1515/cclm-2012-0433

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  3 in total

Review 1.  Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma.

Authors:  Kai Che; Wenkai Han; Mingxin Zhang; Haitao Niu
Journal:  Oncol Lett       Date:  2020-12-24       Impact factor: 2.967

2.  Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.

Authors:  Hyun Suk Yang; Mina Hur; Kyeong Ryong Lee; Hanah Kim; Hahn Young Kim; Jong Won Kim; Mui Teng Chua; Win Sen Kuan; Horng Ruey Chua; Chagriya Kitiyakara; Phatthranit Phattharapornjaroen; Anchalee Chittamma; Thiyapha Werayachankul; Urmila Anandh; Sanjeeva Herath; Zoltan Endre; Andrea Rita Horvath; Paola Antonini; Salvatore Di Somma
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

3.  Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.

Authors:  Raghav Oberoi; Eskindir P Bogalle; Lukas A Matthes; Harald Schuett; Ann-Kathrin Koch; Karsten Grote; Bernhard Schieffer; Jutta Schuett; Maren Luchtefeld
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.